The Efficacy and Safety of Neoadjuvant Trastuzumab Plus Taxane With and Without Pertuzumab Therapy
Clinical trial NCT04765124 · UNKNOWN
Trial details
- NCT number
- NCT04765124
- Sponsor
- Ahmet Bilici
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-04-29
- Primary completion
- 2021-11-15
- Enrollment
- 1500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.